» Articles » PMID: 36341456

Antibody Production in Mice Requires Neither Vitamin D, nor the Vitamin D Receptor

Overview
Journal Front Immunol
Date 2022 Nov 7
PMID 36341456
Authors
Affiliations
Soon will be listed here.
Abstract

The vitamin D receptor as well as its ligand have been localized to various immune tissues and cells. These observations have led researchers to hypothesize a role for vitamin D in the immune system. However, a specific role for vitamin D in immunity has yet to be clearly delineated. The work in this report was undertaken to determine if mounting an antibody response is altered in the face of vitamin D-deficiency or when the signaling pathway is eliminated by removal of the nuclear receptor. This investigation provides direct evidence vitamin D is not necessary for producing antibodies, a process paramount for optimal attack against many foreign organisms. The idea that vitamin D plays a significant role in immunity has been proposed repeatedly for many years. To address this important idea we have carried out studies in mice to determine if vitamin D plays a significant role in antibody production. Two animal models were utilized: mice depleted of vitamin D and mice devoid of the vitamin D receptor. Further, a possible role of hypocalcemia resulting from vitamin D deficiency in antibody production was determined. Neither the absence of vitamin D or the vitamin D receptor nor hypocalcemia affected the ability of mice to mount an antibody response to an antigen challenge. Thus, we found no evidence that vitamin D or normal serum calcium is required for this major form of immunity.

Citing Articles

The active form of vitamin D (calcitriol) promotes CXCR5 expression during follicular helper T cell differentiation.

Iwata M, Takada A, Sakamoto R, Song S, Ito E Int Immunol. 2024; 37(1):53-70.

PMID: 39101520 PMC: 11587897. DOI: 10.1093/intimm/dxae045.


Health Effects of Vitamin D Supplementation: Lessons Learned From Randomized Controlled Trials and Mendelian Randomization Studies.

Bouillon R, LeBoff M, Neale R J Bone Miner Res. 2023; 38(10):1391-1403.

PMID: 37483080 PMC: 10592274. DOI: 10.1002/jbmr.4888.


Highlights from the 24th workshop on vitamin D in Austin, September 2022.

Meyer M, Bernal-Mizrachi C, Bikle D, Biyani M, Campbell M, Chaudhari S J Steroid Biochem Mol Biol. 2023; 228:106247.

PMID: 36639037 PMC: 10006320. DOI: 10.1016/j.jsbmb.2023.106247.

References
1.
Provvedini D, Tsoukas C, Deftos L, Manolagas S . 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J Immunol. 1986; 136(8):2734-40. View

2.
Deluca H . Vitamin D: Historical Overview. Vitam Horm. 2016; 100:1-20. DOI: 10.1016/bs.vh.2015.11.001. View

3.
Charoenngam N, Holick M . Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020; 12(7). PMC: 7400911. DOI: 10.3390/nu12072097. View

4.
Zhu Y, Mahon B, Froicu M, Cantorna M . Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2004; 35(1):217-24. DOI: 10.1002/eji.200425491. View

5.
Ehrchen J, Helming L, Varga G, Pasche B, Loser K, Gunzer M . Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J. 2007; 21(12):3208-18. DOI: 10.1096/fj.06-7261com. View